i696e736967687473o696e6f746976o636f6dz.oszar.com Open in urlscan Pro
172.67.220.76  Public Scan

URL: https://i696e736967687473o696e6f746976o636f6dz.oszar.com/
Submission: On November 10 via api from US — Scanned from DE

Form analysis 2 forms found in the DOM

//i777777o696e6f746976o636f6dz.oszar.com/search-results

<form id="siq_searchForm" action="//i777777o696e6f746976o636f6dz.oszar.com/search-results">
  <input type="search" value="" name="s" class="hs-search-field__input" autocomplete="off" placeholder="What are you looking for?">
  <a class="clear-input-btn">
            ×
          </a>
  <a class="submit-search-btn">
            <svg id="magnifying-glass" viewBox="0 0 16.9 16.9">
              <path d="M16.9,15.4l-4.7-4.7c2.2-3,1.6-7.2-1.4-9.5S3.5-0.3,1.3,2.7s-1.6,7.2,1.4,9.5c2.4,1.8,5.7,1.8,8.1,0l4.7,4.7
  L16.9,15.4z M6.8,11.5C4.1,11.5,2,9.4,2,6.8S4.1,2,6.8,2s4.8,2.1,4.8,4.8S9.4,11.5,6.8,11.5z"></path>
            </svg>
          </a>
</form>

POST

<form action="" method="POST" style="all:unset;float:left;">
  <input type="hidden" name="URL_Adresi" value="https://insights.inotiv.com/">
  <select name="DNS_Adresi" onchange="this.form.submit()" style="all:unset;border:1px solid silver;border-width:0;margin:0px 0px 0px 20px;background-color:transparent;color:black;line-height:20px;text-align:left;padding:0 5px;font-size:14px;">
    <option value="0" selected="true">Otomatik - 199.60.103.254</option>
    <option value="11">CloudFlare DNS</option>
    <option value="12">Türk Telekom DNS</option>
    <option value="13">Google DNS</option>
    <option value="14">Open DNS</option>
  </select>
</form>

Text Content

Skip Navigation
Inotiv
 * Solutions
   * By Therapeutic Area
     * * Cardiovascular
       * Gastrointestinal
       * Hepatic
       * Infectious Disease
     * * Inflammation and Immunology
       * Metabolic and Diabetic Disease
       * Neuroscience
       * Pulmonary
     * * Oncology
       * Renal
   * By Research Phase
     * * Discovery
       * IND-Enabling
       * Pre-Marketing Authorization
   * By Products and Services
     * Discovery and Translational Sciences
       * Disease Pharmacology (in vitro and in vivo)
       * Drug Metabolism and Pharmacokinetics (DMPK) (in vitro and in vivo)
       * Discovery Bioanalysis and Biomarkers
       * Cell and Molecular Biology
       * Predictive and Computational Toxicology
       * Toxicogenomics
       * Targeted Proteomics
       * Histology and Pathology
     * Safety Assessment
       * Toxicology
         * Exploratory Toxicology
         * Genetic Toxicology (GLP and Non-GLP)
         * Safety Pharmacology
         * Developmental and Reproductive Toxicology
         * Carcinogenicity
       * Pathology
       * Bioanalysis: Large Molecule (GLP)
       * Bioanalysis: Small Molecule (GLP)
       * Consulting
       * Archive
       * Surgical Support and Medical Device Testing
         * Medical Device Pathology
     * Research Models and Services
       * Models
         * Find Research Models
         * Models by Therapeutic Area
         * Model Sampling Program
         * Pricing
       * Research Services
         * Genetically Engineered Models and Services (GEMS)
         * Full Spectrum Health Monitoring
         * Custom Antibody Production Services
         * Biospecimen Services
         * Contract Breeding Services
         * Tumor Models and Services
         * Genetic Testing Services
         * Surgical Services
         * Research Model Support Services
       * Resources
         * Eusoft Labs™ (LIMS)
         * LabTracks™
     * Teklad™ Diet, Bedding and Enrichment
       * Teklad Laboratory Animal Diets
         * Standard Natural Ingredient Diets
         * Custom Research Diets
         * Medicated Diets
       * Bedding and Environmental Enrichment Products
         * Contact Bedding
         * Custom-cut Paper Cage Liners
         * Enrichment Products
       * Resources
         * Diet FAQs
         * Phytoestrogen References
         * Shelf Life of Diets Used In Research
       * Ordering
 * Insights
   * Scientific Insights
     * Learn More
   * Blog
     * Learn More
   * Resources
     * Cell Line References
     * Eusoft Labs™ (LIMS)
     * Health Monitoring Reports
     * LabTracks™
     * Safety Assessment Publications
     * Learn More
 * About
   * * Why Inotiv
     * Leadership
     * News and Events
     * About Cumberland
   * * Environmental, Social and Governance (ESG)
     * Regulatory Compliance
     * Global Code of Conduct and Ethics
     * Animal Welfare Statement
   * * Concordat on Openness
     * Global Reach
     * Company History
 * Investors
 * Careers
 * Contact
 * Visit Our Virtual Booth


CLOSE ×
×
 * Home
 * Scientific Insights


SCIENTIFIC INSIGHTS



 * Business area
   Brand / Corporate
   GEMS
   Research and Discovery
   Research models and services
   Safety Assessment
   Teklad

 * Service
   Animal Diets
   Antibody production
   Bedding and enrichment
   Bioanalysis
   COVID
   Clinical Pathology
   Contract breeding
   Cryopreservation
   Developmental and reproductive toxicology
   Diet-induced obesity
   Discovery and Development
   Disease pharmacology (in vitro and in vivo)
   Drug Metabolism and Pharmacokinetics
   Genetic testing
   Genetic toxicology
   Health monitoring
   Investigative Pathology
   Neuroscience
   Pathology
   Proteomics
   Rederivation (speed rederivation)
   Reproductive toxicology (DART)
   Research models
   Safety pharmacology
   Surgical services
   Target sufficiency
   Toxicology

 * Content Type
   Article
   Brochure
   Case Study
   Data/Fact/Tech Sheet
   Discovery
   E-book
   Infographic
   Podcast
   Poster
   Presentation
   Product guide
   Product/Sell sheet
   References
   Scientific Poster
   Speak to an expert
   Video
   Webinar
   White paper

Clear
Search Insights
345 results
Learn more


PIONEERING INVESTIGATIVE TOXICOLOGY FOR SAFER, FASTER DRUG DEVELOPMENT

Inotiv's investigative toxicology expertise drives safe, effective therapies.
Our advanced tools minimize development risks, maximize regulatory success, and
accelerate time to market.
Video
Learn more


IMMUNODEFICIENT MOUSE MODELS TO SUPPORT PROLONGED ENGRAFTMENT OF HUMAN NK AND
TUMOR CELLS

Explore how the B-NDG mouse model supports prolonged engraftment of human cells
for research. Learn about its immunodeficient features and applications in tumor
and stem cell studies. Watch the webinar now!
Webinar
Learn more


TEKLAD TEK TALK WESTERN DIET VIDEO

The Western diet is known for developing phenotypes such as hepatic ballooning,
steatosis, increased focal lobular inflammation, and increased chemokines.
Webinar
Learn more


DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY AND PATHOLOGY

Learn how to evaluate drug effects on fertility and reproduction in a webinar by
Inotiv. Discover how pathology findings inform DART and JAS for improved drug
evaluation.
Webinar
Learn more


WEBINAR—SOD1G93A RAT MODEL OF ALS

Discover how the SOD1G93A rat aids ALS drug discovery. Learn about its
development, motor phenotypes, and biomarkers in this webinar from Inotiv and
Taconic.
Webinar
Learn more


PROPHYLACTIC AND THERAPEUTIC BETA-HYDROXYBUTYRATE IMPROVED MOTOR DYSFUNCTION AND
CORTICAL DAMAGE IN A MOUSE MODEL OF TRAUMATIC BRAIN INJURY

Prophylactic and Therapeutic Beta-Hydroxybutyrate Improved Motor Dysfunction and
Cortical Damage in a Mouse Model of Traumatic Brain Injury
Scientific Poster
Learn more


A TRANSGENIC RAT EXPRESSING THE SOD1-G93A MUTATION EXHIBITS ALS-LIKE PHENOTYPES,
RENDERING IT AN EFFECTIVE TRANSLATIONAL MODEL FOR DRUG DEVELOPMENT

Discover how a transgenic rat model expressing the SOD1-G93A mutation mirrors
ALS-like symptoms, making it a valuable tool for drug development research.
Explore the poster for insights on disease phenotypes and study design.
Scientific Poster
Learn more


MULTIDISCIPLINARY APPROACHES OPTIMIZE CONTRACT DRUG DISCOVERY

Tired of siloed drug development? Inotiv integrates pharmacology, toxicology,
and pathology for a more efficient and cost-effective process. We help you
understand your drug's mechanism of action & potential risks early on.
Article
Learn more


ENHANCED DETECTION SENSITIVITY IN NONCLINICAL CARDIOVASCULAR TELEMETRY STUDIES:
IMPACT OF A CHARACTERIZED FACILITY

Enhanced Detection Sensitivity in Nonclinical Cardiovascular Telemetry Studies:
Impact of a Characterized Facility
Scientific Poster
Learn more


ASSESSMENT OF FACTORS IMPACTING DUPLEXSEQ LIBRARY PERFORMANCE

Assessment of Factors Impacting DuplexSeq Library Performance
Scientific Poster
Learn more


USING HIGH-RESOLUTION MASS SPECTROMETRY AND SOFTWARE AIDED METABOLITE ASSESSMENT
FOR CYTOCHROME P450 REACTION PHENOTYPING OF LOW CLEARANCE SMALL MOLECULE DRUGS

Using High-Resolution Mass Spectrometry and Software Aided Metabolite Assessment
for Cytochrome P450 Reaction Phenotyping of Low Clearance Small Molecule Drugs
Scientific Poster
Learn more


THINKING BEYOND CYTOCHROME P450 INACTIVATION KINETICS ENHANCED UNDERSTANDING OF
THE MECHANISM OF TUCATINIB INTERACTION WITH CYP3A4

Tucatinib is effective against HER2+ breast cancer, including brain metastases.
In vitro studies identified time-dependent inhibition of CYP3A4 by tucatinib,
though with low inactivation efficiency. Poster highlights mechanism.
Scientific Poster
 * «
 * ‹
 * 1
 * 2
 * 3
 * ›
 * »




SUBSCRIBE TO UPDATES FROM INOTIV

Sign up and you’ll receive the latest updates that matter to you, delivered
straight to your inbox.

Subscribe now  

Inotiv

 * 
 * 

Copyright © 2024 Inotiv. All Rights Reserved.

 * Terms of Use
 * Privacy Policy
 * Do Not Sell Or Share My Information
 * Accessibility Statement
 * Cookie Statement

Envigo
Toggle navigation
 * Products and services
   * Research models
   * Research services
   * Teklad diet, bedding and enrichment
 * Resources
   * Scientific insights
   * Blog
   * News
   * Events
 * About
   * Executive leadership
   * Our brand story
   * Vision, mission and values
   * Corporate social responsibility
   * Our use of animals
 * Contact
 * Legal
   * Terms of use
   * Privacy policy
   * Cookie statement
   * Our use of animals
     


Please ensure Javascript is enabled for purposes of website accessibility
Otomatik - 199.60.103.254 CloudFlare DNS Türk Telekom DNS Google DNS Open DNS
OSZAR »